Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
DSFE & Lif Whitepaper on
Industry-Academia Collaborations
Anton Pottegård
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Aim
Inthisjointpaper,DSFEandLifwishestodescribethetwoassocia0ons'approachtotheuseofhealthdatafromDanishregistriesand
setouttheprinciplesforcollabora0onbetweenpublicsectorresearchersandthe
pharmaceu<calindustryforpharmacoepidemiologicalstudies.
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
The reality of Real World Data in a Nordic context
Possibilities and barriers for collaboration
between academia and industry
Anton Pottegård
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Conflicts of interest
I have participated in research projects funded by
Alcon, Almirall, Astellas, Astra-Zeneca, Boehringer-Ingelheim, and Servier, all with
funds paid to the institution where I am employed. I have never received any personal fees.
All are irrelevant to this presentation
extremely
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Safety comes first… Guidelines are available…
It’s nice to have a coordinating center… We need to understand one another…
Communication is key… Legislation is in place, but room for improvement…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
”pretty picture”
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Safety comes first…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Safety comes first…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
1 of 4
Safety comes first…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Safety studies
Utilization studies Pragmatic trials
Comparative-effectiveness studies Creative uses…
Safety comes first…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
2 of 4
Guidelines are available…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
You need a thorough (preplanned) study protocol
The academic partner needs the right to publish
the study findings, regardless of outcome
Guidelines Good Pharmacovigilance Practice (GVP), Module VIII [EMA]
Good Pharmacoepidemiological Practice (GPP) [ISPE] Code of Conduct [ENCePP]
Guidelines are available…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
3 of 4
It’s nice to have a coordinating center…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Coordinating center…
Research partners
Sponsor
CRO/ARO
EMA
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
But why?
1) Double arms length is always nice (especially in studies of safety concerns!)
2) We know them and they know us and our data 3) They take care of all the bureauratic bull**** 4) They have access to ad-hoc experts 5) They can focus on (and have specific expertise in)
facilitating the process 6) They are in a better position to ‘push back’ if either
academia or industry does not behave 7) They know enough about both worlds (industry and
academia) to translate…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
4 of 4
We need to understand one another…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Study centers
Sponsor
CRO/ARO
EMA
Understand one another…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Why ”start of data collection”? Why such a horribly convoluted protocol?
Why such weird headers for the final study report?
Answer: GVP Module VIII.B
Understand one another…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Contract research vs.
Research collaborations
Understand one another…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Safety comes first… Guidelines are available…
It’s nice to have a coordinating center… We need to understand one another…
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
We need to use these data … with due respect to data privacy.
Both parties needs relevant competencies. Current collaborations live up to this!
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Guidelines Good Pharmacovigilance Practice (GVP), Module VIII [EMA]
Good Pharmacoepidemiological Practice (GPP) [ISPE] Code of Conduct [ENCePP]
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Highlights Contractual basis
Publication of scientific results Relevant competencies
Involvement of third party
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Relevant competencies
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Proposal
Reading material - GPP - GVP, modul VIII - ENCePP - Previous protocols - Previous study reports
Introduction
Industry-track
Academia-track
Joint sessions
Dansk Selskab for Farmakoepidemiologi / Danish Society for Pharmacoepidemiology, [email protected]
Anton Pottegård [email protected]
Acknowledgments
Jesper Hallas Jordi Castellsague
Michael Busch-Sørensen Susana Perez-Gutthann
Morten Andersen Kari Furu
Helle Kieler Espen Jimenez Solem
Jakob Bjerg Larsen The DSFE board